血清卵泡抑素在甲状腺癌中升高并与不良肿瘤特征相关
一项医院来源的非匹配病例对照研究纳入170例分化型甲状腺癌术后患者与106例无恶性肿瘤史的甲状腺切除患者,术后45天稳态采血。结果显示甲状腺癌患者血清卵泡抑素(FST)水平高于无癌个体,且最高三分位与各组织学亚型甲状腺癌风险升高相关,并与血管侵犯、远处转移及诊断时TNM分期相关。
要点
- 甲状腺癌术后患者血清FST水平高于无癌对照,且不依赖组织学亚型。
- FST最高三分位与甲状腺癌及其乳头状、滤泡状、Hürthle细胞及髓样癌风险升高相关。
- 术后FST较高与血管侵犯、远处转移及诊断时TNM分期相关。
核心结论
- 甲状腺癌患者血清FST水平升高,并与肿瘤侵袭性相关,但需未来纵向研究证实与扩展。
研究设计与样本
- 医院来源的非匹配病例对照研究,纳入170例因分化良好的甲状腺癌行甲状腺切除的患者与106例无恶性肿瘤史的甲状腺切除患者。
- 记录人体测量学、生化及组织学参数,术后45天稳态采集血清,用高特异性ELISA检测FST、FSTL3、激活素A、激活素B、生物活性IGF-1及STC2。
- 采用多变量模型校正非匹配变量的基线差异。
主要发现
- 非匹配单变量模型中,甲状腺癌患者血清FST水平高于无癌个体,且独立于组织学亚型。
- 多变量校正模型中,FST水平最高三分位与任何类型甲状腺癌及乳头状、滤泡状、Hürthle细胞癌和髓样甲状腺癌风险升高相关。
- 术后FST浓度较高见于有血管侵犯和远处转移的患者,并与诊断时TNM分期相关。
临床怎么用
- 血清FST有望作为甲状腺癌风险评估的候选生物标志物,但当前证据来自病例对照研究,尚不足以直接用于临床决策。
局限性
- 为非匹配病例对照设计,组间基线差异需多变量校正。
- 样本来自单中心术后45天稳态采血,结论需未来纵向研究确认与扩展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Obesity and classical growth factors are associated with thyroid cancer (TC). However, less is known regarding novel hormones such as follistatins and activins. We hypothesized that serum follistatin but not activins would be increased in TC. OBJECTIVE: This work aimed to assess circulating levels of follistatins, activins, and growth factors in patients with a history of TC vs patients with nonmalignant thyroid diseases. METHODS: A hospital-based, unmatched case-control study was conducted with 170 thyroidectomized patients due to well-differentiated TC and 106 thyroidectomized patients without history of malignancy. Anthropometric, biochemical, and histological parameters were recorded. Serum samples were collected in the steady state 45 days after surgery. Multivariate models were used to adjust for baseline differences of the unmatched variables. Serum levels of follistatin (FST), follistatin like-3, activin A, activin B, bioactive insulin-like growth factor-1, and stanniocalcin-2 were assayed with novel, highly specific ELISA kits. RESULTS: In unmatched univariate models, TC patients had higher FST serum levels compared to cancer-free individuals, independently of histological subtype. In multivariate models adjusting for covariates, individuals in the highest tertile of FST levels were associated with an increased risk for the presence of any type of TC or specific histological subtypes, including papillary, follicular and Hürthle-cell carcinoma, and medullary TC. Higher postoperative FST concentrations were found in patients with vascular invasion and distant metastases and associated with TNM staging at diagnosis. CONCLUSION: FST serum levels are increased in TC patients and correlate with advanced tumor aggressiveness. Future longitudinal studies are needed to confirm and extend our observations.
引用
- Panagiotou G, Ghaly W, Upadhyay J, et al. Serum Follistatin Is Increased in Thyroid Cancer and Is Associated With Adverse Tumor Characteristics in Humans. J Clin Endocrinol Metab. 2021. PMID: 33493282. doi:10.1210/clinem/dgab041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。